Skip to main content
Indietro

Antimicrobial Drugs: Mechanisms, Spectrum, and Resistance

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are essential tools in modern medicine, designed to inhibit or kill pathogenic microorganisms while minimizing harm to the host. Their effectiveness depends on selective toxicity, which is the ability to target microbial processes without affecting human cells.

  • Chemotherapy: The use of chemical agents to treat disease, especially infections.

  • Antimicrobial drugs: Compounds that interfere with the growth of microbes within a host.

  • Antibiotics: Substances produced by microbes that inhibit other microbes in small amounts.

  • Selective toxicity: The property of a drug to kill harmful microbes without damaging the host.

Spectrum of Activity

Antimicrobial drugs vary in their spectrum of activity, which refers to the range of microorganisms they affect. Narrow-spectrum drugs target specific groups, while broad-spectrum drugs affect a wide variety of organisms.

  • Narrow-spectrum: Effective against a limited group of bacteria.

  • Broad-spectrum: Effective against many groups of microorganisms.

  • Superinfection: An infection caused by drug-resistant microorganisms during antimicrobial therapy.

Spectrum of Activity of Antibiotics and Other Antimicrobial Drugs

Mechanisms of Action of Antimicrobial Drugs

Overview of Mechanisms

Antimicrobial drugs act through several distinct mechanisms, each targeting a specific aspect of microbial physiology.

  • Inhibition of cell wall synthesis: Penicillins, cephalosporins, bacitracin, vancomycin.

  • Inhibition of protein synthesis: Chloramphenicol, erythromycin, tetracyclines, streptomycin.

  • Inhibition of nucleic acid replication and transcription: Quinolones, rifampin.

  • Injury to plasma membrane: Polymyxin B.

  • Inhibition of essential metabolite synthesis: Sulfanilamide, trimethoprim.

Mechanisms of Action of Antimicrobial Drugs

Inhibition of Protein Synthesis

Protein synthesis inhibitors target the bacterial ribosome, which differs structurally from the eukaryotic ribosome, allowing selective toxicity. Drugs act at various points in the translation process.

  • Streptomycin: Changes the shape of the 30S ribosomal subunit, causing misreading of mRNA.

  • Tetracyclines: Interfere with the attachment of tRNA to the mRNA–ribosome complex.

  • Chloramphenicol: Binds to the 50S subunit and inhibits peptide bond formation.

Protein Synthesis Site and Antibiotic Action

Determination of Microbial Susceptibility

Testing Methods

To determine the effectiveness of antimicrobial drugs, laboratory tests are performed to assess microbial susceptibility.

  • Minimal Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible growth of a microorganism.

  • Broth or tube dilution method: Serial dilutions of antibiotics to determine MIC; accurate but time-consuming.

  • Disk sensitivity test: Rapid method using antibiotic-impregnated disks; results must be correlated with MIC.

  • Epsilometer (E) test: Provides graded exposure to chemotherapeutic agents and determines MIC directly.

Disk-Diffusion Test for Antibiotic Sensitivity Epsilometer Test for MIC Determination

Cell Wall Synthesis Inhibitors

β-lactam Antibiotics

β-lactam antibiotics are a major class of cell wall synthesis inhibitors, characterized by a four-membered β-lactam ring. They target penicillin-binding proteins (PBPs) involved in peptidoglycan synthesis.

  • Penicillins: Over 70 compounds; natural penicillins have a narrow range and are susceptible to penicillinase (β-lactamase).

  • Semisynthetic penicillins: Modified in the laboratory for broader spectrum and resistance to β-lactamase.

  • Cephalosporins: Similar structure to penicillins but with a different ring, resistant to β-lactamase, broader spectrum.

  • Monobactams and carbapenems: Other β-lactam families with clinical utility.

Penicillin Structure and Penicillinase Action β-lactam Ring Structure Cephalosporin and Penicillin Nucleus Structures

Bacitracin and Vancomycin

Bacitracin and vancomycin are non-β-lactam cell wall inhibitors. Bacitracin prevents peptidoglycan monomer transport and is used topically due to toxicity. Vancomycin prevents addition of peptidoglycan subunits and is used for serious infections resistant to penicillins.

Antimycobacterial Agents

Agents such as isoniazid and ethambutol target mycobacteria by inhibiting mycolic acid synthesis, essential for cell wall integrity.

Isoniazid Structure Ethambutol Structure

Protein Synthesis Inhibitors

Aminoglycosides

Aminoglycosides are broad-spectrum, bactericidal drugs that bind to the 30S ribosomal unit, causing misreading of mRNA. They are mainly used for Gram-negative infections and are reserved due to toxicity.

Streptomycin Structure

Tetracyclines

Tetracyclines inhibit the binding of aminoacyl tRNA to the 30S ribosomal subunit. They are broad-spectrum but can affect bone development and stain teeth in children.

Tetracycline Structure

Chloramphenicol

Chloramphenicol binds to the 50S ribosomal subunit and blocks peptide bond formation. It is a potent inhibitor of mitochondrial protein synthesis in eukaryotic cells and must be used with caution.

Chloramphenicol Structure

Macrolides

Macrolides, such as erythromycin and clarithromycin, bind to the 50S ribosomal subunit and inhibit peptidyl transferase activity or translocation. They are relatively non-toxic and widely used.

Erythromycin Structure

Streptogramins

Streptogramins are a combination of two types: A (distorts ribosome, prevents tRNA binding) and B (blocks peptide translocation). Both inhibit bacterial protein synthesis.

Streptogramin A Structure Streptogramin B Structure

Plasma Membrane Injury

Polymyxins and Gramicidin

These drugs disrupt the bacterial cell membrane, increasing permeability and causing cell death. Polymyxins are active against Gram-negative bacteria, while gramicidin targets Gram-positive bacteria. Both are toxic to humans and used topically.

Inhibitors of Nucleic Acid Synthesis

Sulfonamides

Sulfonamides inhibit folic acid synthesis by acting as structural analogs of PABA, blocking dihydropteroate synthetase. This interrupts nucleic acid metabolism and leads to bacterial death.

Sulfonamide Structure and Pathway

Competitive Inhibitors

Competitive inhibitors bind to the active site of enzymes, preventing the normal substrate from binding. This mechanism is used by sulfonamides and other drugs.

Competitive and Non-competitive Enzyme Inhibition

Quinolones

Quinolones inhibit bacterial DNA gyrase, preventing DNA replication. Examples include norfloxacin, ofloxacin, and ciprofloxacin. Human DNA gyrase is structurally distinct and unaffected.

Ciprofloxacin Structure

Rifamycin

Rifamycin prevents production of mRNA, stopping protein synthesis. It is used in treating tuberculosis and for prophylaxis against meningococcal meningitis.

Antifungal Drugs

Inhibition of Ergosterol Synthesis

Fungal cell membranes contain ergosterol, making it a prime target for antifungal agents. Polyenes bind to ergosterol, disrupting membrane integrity, while imidazoles and triazoles inhibit ergosterol synthesis.

  • Polyene antifungals: Nystatin (topical), Amphotericin B (systemic).

  • Imidazoles and triazoles: Miconazole, ketoconazole; broad-spectrum activity.

Inhibition of Nucleic Acids

Flucytosine is a cytosine analog that interferes with RNA synthesis, selectively toxic to fungi.

Inhibition of Microtubules (Mitosis)

Griseofulvin binds to proteins involved in microtubule formation, preventing chromosome separation during mitosis. Used for ringworm and other skin/nail fungal infections.

Antiviral Drugs

Nucleoside and Nucleotide Analogs

Antiviral drugs often target viral enzymes involved in nucleic acid synthesis. Acyclovir and zidovudine (AZT) are nucleoside analogs that inhibit viral DNA polymerase.

Nucleoside and Nucleotide Analogs Acyclovir Mechanism of Action

Acyclovir

Acyclovir inhibits the thymidine kinase of herpes viruses, blocking DNA synthesis. It is used for severe cases of genital herpes and is active only in virus-infected cells.

Acyclovir Structure Ganciclovir Structure

Viral Enzyme Inhibitors

Protease inhibitors (e.g., indinavir for HIV) prevent processing of viral proteins. Zanamivir and amantadine inhibit release and uncoating of influenza viruses. Interferons prevent spread of viruses to new cells.

Antibiotic Resistance

Mechanisms of Resistance

Bacteria have evolved multiple strategies to resist antibiotics, including blocking entry, inactivation by enzymes, alteration of target molecules, and efflux of antibiotics.

Antibiotic Resistance Selection Mechanisms of Antibiotic Resistance

  • Blocking entry: Preventing drug from entering the cell.

  • Inactivation by enzymes: Enzymatic destruction or modification of the drug.

  • Alteration of target molecule: Changing the drug's binding site.

  • Efflux of antibiotic: Pumping the drug out of the cell.

Inappropriate Antimicrobial Use

Misuse of antibiotics accelerates the development of resistance. Common misuse includes using outdated drugs, incomplete regimens, and unnecessary prescriptions.

Combating Resistance

Strategies to combat resistance include developing new antibiotics, tracking resistance, restricting use, employing narrow-spectrum drugs, and using drug combinations.

Effects of Drug Combinations

Drug combinations can result in synergism (greater effect together) or antagonism (reduced effect together). For example, penicillin is antagonized by tetracycline.

Synergistic and Antagonistic Effects of Drug Combinations

Pearson Logo

Study Prep